• Ancliff, P., Liesner, R., Khair, K. & Hann, I. (1999) The use of recombinant factor VIIa in a patient with severe Glanzmann thrombasthenia to facilitate insertion of a Port-a-Cath®. Blood Coagulation and Fibrinolysis, 10, 447448.
  • Bellucci, S. & Caen, J. (2002) Molecular basis of Glanzmanns thrombasthenia and current strategies in treatment. Blood Reviews, 16, 193202.
  • Brown, III, C.H., Weisberg, R.J., Natelson, E.A. & Alfrey, Jr, C.P. (1975) Glanzmann thrombasthenia: assessment of the response to platelet transfusions. Transfusion, 15, 124131.
  • Chuansumrit, A., Sangkapreecha, C. & Hathirat, P. (1999) Successful epistaxis control in a patient with Glanzmanns thrombasthenia by increased bolus injection dose of recombinant factor VIIa. Thrombosis and Haemostasis, 82, 1778.
  • Gerotziafas, G.T., Zervas, C., Gavrielidis, G., Tokmaktsis, A., Hatjiharissi, E., Papaioannou, M., Lazaridou, A., Constantinou, N., Samama, M.M. & Christakis, J. (2002) Effective hemostasis with rFVIIa treatment in two patients with severe thrombocytopenia and life-threatening hemorrhage. American Journal of Hematology, 69, 219222.
  • Hedner, U. (1996) Dosing and monitoring of Novo Seven treatment. Haemostasis, 26, 102108.
  • Hoffman, M. & Monroe, D.M. (2001) A cell based model of haemostasis. Thrombosis and Haemostasis, 85, 958965.
  • Ingerslev, J., Chritiansen, K., Calatzis, A., Holm, M. & Sabroe-Ebbesen, L. (2000) Management and monitoring of recombinant activated factor VII. Blood Coagulation and Fibrinolysis, 11, s25s30.
  • Johannessen, M., Nielsen, G. & Nordfang, O. (2000) Comparison of the factor VII:C clot analysis and a modified activated factor VII analysis for monitoring factor VII activity in patients treated with recombinant factor VII (NovoSeven). Blood Coagulation and Fibrinolysis, 11, s159s164.
  • Kjalke, M., Ezban, M., Monroe, D.M., Hoffman, M., Roberts, H.R. & Hedner, U. (2001) High dose factor VIIa increases thrombin generation and mediates faster platelet activation in thrombocytopenia-like conditions in a cell-based model system. British Journal of Haematology, 114, 114120.
  • Monroe, D.M., Hoffman, M., Oliver, J.A. & Roberts, H.R. (1997) Platelet activity of high-dose factor VIIa is independent of tissue factor. British Journal of Haematology, 99, 542547.
  • Monroe, D.M., Hoffman, M. & Roberts, H.R. (2002) Platelets and thrombin generation. Arteriosclerosis, Thrombosis and Vascular Biology, 22, 13811389.
  • Monte, S. & Lyons, G. (2002) Peripartum management of a patient with Glanzmanns Thrombasthenia using thromboelastograph. British Journal of Anaesthetics, 5, 734738.
  • D'Orion, R., Menart, C., Trzeciak, M.C., Nurden, P., Fressinaud, E., Dreyfus, M., Laurian, Y. & Negrier, C. (2000) Use of recombinant factor VIIa in 3 patients with inherited type I Glanzmann thrombasthenia undergoing invasive procedures. Thrombosis and Haemostasis, 83, 637638.
  • Peters, M. & Heijboer, H. (1998) Treatment of a patient with Bernard–Soulier syndrome and recurrent nosebleeds with recombinant factor VIIa. Thrombosis and Haemostasis, 80, 352.
  • Poon, M.C. & D'Orion, R. (2000) Recombinant activated factor VII (Novoseven) treatment of platelet-related bleeding disorders. International Registry on Recombinant factor VIIa and Congenital Platelet Disorders Group. Blood Coagulation and Fibrinolysis, 11, s55s68.
  • Poon, M., Demers, C., Jobin, F. & Wu, J.W.Y. (1999) Recombinant factor VIIa is effective for bleeding and surgery in patients with Glanzmann thrombasthenia. Blood, 94, 39513953.
  • Poon, M.C., D'Orion, R., Hann, I., Négrier, C., De Lumley, L., Thomas, A., Karafoulidou, A., Demers, C., Street, A., Huth-Kühne, A., Petrini, P., Fressinaud, E., Morfini, M., Tengborn, L., Marquès-Verdier, A., Musso, R., Devecioglu, O., Houston, D.S., Lethagen, S., Van Geet, C., Von Depka, M., Berger, C., Beurrier, P., Britton, H.A., Gerrits, W., Guthner, C., Kuhle, S., Lorenzo, J., Makris, P., Nohe, N., Paugy, P., Pautard, B., Torchet, M., Trillot, N., Vicariot, M., Wilde, J., Winter, M., Chambost, H., Ingerslev, J., Peters, M. & Strauss, G. (2001) Use of recombinant factor VIIa (Novoseven®) in patients with Glanzmann thrombasthenia. Seminars in Haematology, 38, s21s25.
  • Tengborn, L. & Petruson, B. (1996) A patient with Glanzmann thrombasthenia and epistaxis successfully treated with recombinant factor VIIa. Thrombosis and Haemostasis, 75, 981982.
  • Vidarsson, B. & Onundarson, P.T. (2000) Recombinant factor VIIa for bleeding in refractory thrombocytopenia. Thrombosis and Hemostasis, 83, 634635.
  • Wong, W.Y., Huang, W.C., Miller, R., McGinty, K. & Whishnant, J.K. (2002) Clinical efficacy and recovery levels of recombinant FVIIa (NovoSeven) in the treatment of intracranial haemorrhage in severe neonatal FVII deficiency. Haemophilia, 1, 5054.